| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 10/17/2001 | EP1144364A2 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 10/17/2001 | EP1144362A1 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors |
| 10/17/2001 | EP1144348A2 Lta 4? hydrolase inhibitors |
| 10/17/2001 | EP1144305A1 NOVEL sPLA 2 INHIBITORS |
| 10/17/2001 | EP1143985A2 Use of lactobacillus salivarius |
| 10/17/2001 | EP1143984A1 Egg anti-inflammatory composition and method of treating and preventing inflammation |
| 10/17/2001 | EP1143977A1 2-oxy-benzoxazinone derivatives for the treatment of obesity |
| 10/17/2001 | EP1143965A1 Carbocyclic potassium channel inhibitors |
| 10/17/2001 | EP1143964A1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission |
| 10/17/2001 | EP1143961A2 Regulators of the ptc or smoothened pathway, compositions and uses related thereto |
| 10/17/2001 | EP1143960A2 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases |
| 10/17/2001 | EP1143956A2 Compositions and methods for the treatment of anorectal disorders |
| 10/17/2001 | EP1143946A2 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 10/17/2001 | EP1143944A2 Use of arylalkanoylpyridazines |
| 10/17/2001 | EP1143940A2 Compositions and methods for mucosal delivery |
| 10/17/2001 | EP1143932A1 Transnasal transport/immunisation with highly adaptable carriers |
| 10/17/2001 | EP1143913A1 Preparation for dental treatment |
| 10/17/2001 | EP1143806A2 Method for increasing pet activity |
| 10/17/2001 | EP1143805A2 Methods for reducing mortality rates in poultry |
| 10/17/2001 | EP1001955B1 1,2,4-triazolo 4,3-b]pyrido 3,2-d]pyridazine derivatives and pharmaceutical compositions containing them |
| 10/17/2001 | EP0808103A4 Protein hydroxylation inhibitors for fibroproliferative disorders |
| 10/17/2001 | EP0652871B1 Benzodiazepine derivatives |
| 10/17/2001 | CN1318065A Novel salt form of pantoprazole |
| 10/17/2001 | CN1318056A Pyridinum derivatives for management of aging-related and diabetic vascular complications, process for their prepn. and therepeutic uses thereof |
| 10/17/2001 | CN1318054A Novel compounds |
| 10/17/2001 | CN1317971A Antiviral combination comprising lamivudine and abacavir |
| 10/17/2001 | CN1317968A 2-bustituted-1-piperidyl benzimidazole compounds as or/1-receptor agonists |
| 10/17/2001 | CN1317961A Compsn. contg. cinnamic acid derivatives for preventing or treating elevated blood lipid level-releated diseases |
| 10/17/2001 | CN1317938A Compsn. contg. neohesperidin dihydrochalcone for preventing or treating elevated blood lipid and glucose level-reated diseases |
| 10/17/2001 | CN1317937A Compsn. containing natural phenolic compound for preventing or treating elevated blood liquid level-related diseases |
| 10/17/2001 | CN1317563A Medical tonic 5-snake wine |
| 10/17/2001 | CN1317336A Extraction and clinical application research of 'Jiechangshu' capsule |
| 10/17/2001 | CN1317332A Health five-snake wine for treating rheumatism |
| 10/17/2001 | CN1317328A Medicine for stomatitis |
| 10/17/2001 | CN1317323A Soft capsule of notogenseng pollen |
| 10/17/2001 | CN1317318A Prescription and process for preparing compound amino acid capsule |
| 10/17/2001 | CN1073154C Superoxide dismutase-4 |
| 10/17/2001 | CN1072959C Medicine for treating gastritis, gastric ulcer and duocenal ulcer and its prepn. method |
| 10/17/2001 | CN1072953C Medicine for treating digestive system diseases and its prepn. method |
| 10/17/2001 | CN1072950C Traditional Chinese medicinal powder for treating oral diseases, and method for preparing same |
| 10/17/2001 | CN1072949C Medicine for treating anorexia |
| 10/17/2001 | CN1072941C Compounding process for oral liquid for liver and bile stone |
| 10/17/2001 | CN1072938C Traditional chinese medicine for curing gastric disease |
| 10/17/2001 | CN1072932C Method of preventing emesis and treating sexual dyfunction using tetra hydrobenz [CD] indole-6-carboxamides |
| 10/16/2001 | US6303790 Process for the preparation of pyridine derivatives |
| 10/16/2001 | US6303788 Process for preparing omeprzole |
| 10/16/2001 | US6303643 Therapy of migraine headache, hypertension, alcohol withdrawal, drug addiction, rheumatoid arthritis, presbyopia, ischemic pain, spasticity, diarrhea, nasal congestion, and urinary incontinence by administering benzothiazole derivative |
| 10/16/2001 | US6303637 For therapy of autoimmune disease, prophylaxis of resistance to transplantation or transplantation rejection of organs or tissues; suppressing immune system |
| 10/16/2001 | US6303636 Arylsulfonylamino hydroxamic acid derivatives |
| 10/16/2001 | US6303614 Tetrahydro gamma-carbolines |
| 10/16/2001 | US6303608 2-{4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimidine, its preparation and its therapeutic use |
| 10/16/2001 | US6303603 3-oxo-2(H)-1,2,4-triazine derivatives as ligands of 5 HT1A receptors |
| 10/16/2001 | US6303602 Useful as analgesic, anesthetic, anti-inflammatory or neuroprotective agent, or for therapy of arthritis, stroke of functional bowel disease |
| 10/16/2001 | US6303601 Arylgycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 10/16/2001 | US6303572 Control of acidic gut syndrome |
| 10/16/2001 | US6303374 By hybridization with nucleic acid; controlling apoptosis and programmed cell death; alzheimer*s, parkinson*s, autoimmune, and viral diseases; cancer; amyotrophic lateral sclerosis |
| 10/16/2001 | US6303333 Expression vector which codes polypeptides for the diagnosis and treatment of cancer, dietetics, inflammation, cardiovascular disorders, crohn's diseases, neuropathies and immune defects |
| 10/16/2001 | US6303314 T-cell receptor Vβ-Dβ-Jβ sequence and methods for its detection |
| 10/16/2001 | US6303127 Treatment of disease states |
| 10/16/2001 | US6303126 Treatment of fibrosis by HGF |
| 10/16/2001 | CA2241464C Nisin in combination with glycerol monolaurate active against helicobacter |
| 10/16/2001 | CA2036463C Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines |
| 10/14/2001 | CA2344183A1 Glycoprotein having inhibitory activity against helicobacter pylori colonization |
| 10/11/2001 | WO2001075081A1 Methods for identifying compounds useful for inhibiting geranylgeranyl diphosphate synthase |
| 10/11/2001 | WO2001075074A1 Novel proteins |
| 10/11/2001 | WO2001074903A2 CD20/IgE-RECEPTOR LIKE MOLECULES AND USES THEREOF |
| 10/11/2001 | WO2001074902A2 Adenine binding g protein coupled receptors |
| 10/11/2001 | WO2001074896A1 Human polynucleotides, polypeptides, and antibodies |
| 10/11/2001 | WO2001074806A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain |
| 10/11/2001 | WO2001074805A1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain |
| 10/11/2001 | WO2001074804A1 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatement of pain |
| 10/11/2001 | WO2001074780A1 Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist |
| 10/11/2001 | WO2001074769A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| 10/11/2001 | WO2001074763A1 Aryl and heteroaryl sulfonates |
| 10/11/2001 | WO2001074413A1 Medical devices suitable for gene therapy regimens |
| 10/11/2001 | WO2001074370A1 Use of feracryl for the treatment of peptic/duodenal ulcer and/or cholera |
| 10/11/2001 | WO2001074359A1 Sigma receptor ligands and their medical uses |
| 10/11/2001 | WO2001074344A2 Small organic molecule regulators of cell proliferation |
| 10/11/2001 | WO2001074324A1 New formulations for the removal of dental plaque, tartar and dental stains |
| 10/11/2001 | WO2001074180A1 Nutritional supplements for stimulating bone growth |
| 10/11/2001 | WO2001036640A3 Human fgf-21 gene and gene expression products |
| 10/11/2001 | WO2001034572A3 Carboxamide-substituted benzimidazol derivatives, method for the production thereof and their use as tryptase inhibitors |
| 10/11/2001 | WO2001025269A3 Human g-protein coupled receptor |
| 10/11/2001 | WO2001025210A3 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands |
| 10/11/2001 | WO2001021587A3 Hydroxyfunctional amide 1h-indole derivatives active as spla2 inhibitors |
| 10/11/2001 | WO2001021202A3 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
| 10/11/2001 | WO2001019826A3 Triazolopyrimidine derivatives |
| 10/11/2001 | WO2001012264A3 Topical azathioprine for the treatment of oral autoimmune diseases |
| 10/11/2001 | WO2001007470A3 Human nervous system-associated proteins |
| 10/11/2001 | WO2000062736A3 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion |
| 10/11/2001 | WO2000042429A3 In vitro model for gastrointestinal inflammation |
| 10/11/2001 | US20010029304 Cyclopentane heptan (ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 10/11/2001 | US20010029249 Adenovirus comprising a gene coding for glutathione peroxidase |
| 10/11/2001 | US20010029020 In vitro determination of metastatic stomach, esophageal, and colorectal cancer from sampling cells outside of the colorectal track for gene transcript or protein |
| 10/11/2001 | US20010029019 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 10/11/2001 | US20010028899 Composition for supprssing cellular fibrousing and method for preparing an extract from loquat seeds |
| 10/11/2001 | EP1145001A3 (in vitro) model for gastrointestinal inflammation |
| 10/11/2001 | DE10015866A1 Aryl- und Heteroarylsulfonate Aryl and Heteroarylsulfonate |
| 10/11/2001 | DE10015783A1 Transdermales therapeutisches System zur Abgabe von Lerisetron Transdermal therapeutic system for the delivery of lerisetron |
| 10/11/2001 | CA2405131A1 New formulations for the removal of dental plaque, tartar and dental stains |